Review Article
A Methodical Review on the Applications and Potentialities of Using Nanobiosensors for Disease Diagnosis
Table 3
Some reported commercialized BioSS/NanoBioSS for biomedical/clinical/healthcare applications.
| Target analyte | Linked disorder | Type of BioSS/NanoBioSS | Reference |
| Glucose | DBT | Enzymatic-ETC NanoBioSS, lateral flow (LF) immunochromatographic (ICM) assays reverse iontophoresis | [147] | Human chorionic gonadotropin (hCG) | Gestation, fertility, and ovulation | LF ICM assay, FRS-labeled AB assay | [148] | Streptococci spp. | Diseases of the throat or skin | LF ICM assay, FRS-labeled AB assay | [149, 150] | Mycobacterium tuberculosis | Tuberculosis | LF ICM assay, FRS-labeled AB assay | [151] | Alpha-fetoprotein (AFP) | Cancerous complications | LF ICM assay, ETC | [152] | Bacillus anthracis | Anthrax | Standard LF assay, FRS-labeled AB assay | [153] |
|
|